Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study.
Andrew N Menzies-GowClaire McBrienBindhu UnniCeleste M PorsbjergMona Al AhmadChristopher S AmbroseKarin Dahl AssingAnna von BülowJohn BusbyBorja García CosioJ Mark FitzGeraldEsther Garcia GilSusanne HansenLiam G aHeaneyMark HewDavid J JacksonMaria KallieriStylianos LoukidesNjira L LugogoAndriana I PapaioannouDésirée Erlinda Larenas-LinnemannWendy C MooreLuis A Perez-de-LlanoLinda M RasmussenJohannes M SchmidSalman SiddiquiMarianna AlacquaTrung N TranCharlotte Suppli UlrikJohn W UphamEileen WangLakmini BulathsinhalaVictoria A CarterIsha ChaudhryNeva EleangovanRuth B MurrayChris A PriceDavid J PricePublished in: Journal of asthma and allergy (2022)
The description of real-life patterns of continuing, stopping, or switching biologics enhances our understanding of global biologic use. Prospective studies involving structured switching criteria could ascertain optimal strategies to identify patients who may benefit from switching.